NCT02424630

Brief Summary

The investigators compared the results of sono-guided interscalene brachial plexus block (ISB) combined with arthroscopy-guided suprascapular nerve block (SSNB) with those of ISB alone within the first 48 h after arthroscopic rotator cuff repair.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 23, 2015

Completed
5.4 years until next milestone

Results Posted

Study results publicly available

August 27, 2020

Completed
Last Updated

August 27, 2020

Status Verified

August 1, 2020

Enrollment Period

11 months

First QC Date

April 17, 2015

Results QC Date

January 29, 2016

Last Update Submit

August 25, 2020

Conditions

Keywords

sono-guided interscalene brachial plexus blockarthroscopy-guided suprascapular nerve blockarthroscopic rotator cuff repairpostoperative pain

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS) Pain Score

    The VAS pain score was based on a scale from 0 to 10, where 0 indicated no pain and 10 indicated severe pain

    1, 3, 6, 12, 18, 24, 36, 48h

Secondary Outcomes (1)

  • Patient Satisfaction (SAT) Score

    1, 3, 6, 12, 18, 24, 36, 48h

Study Arms (2)

ISB with SSNB

EXPERIMENTAL

During arthroscopic rotator cuff repair, ultrasound-guided ISB was performed preemptively with 7.5 mL ropivacaine immediately after general anesthesia was induced. And at the end of surgery, arthroscopy-guided SSNB was performed with 10 mL ropivacaine.

Device: Ultrasound-guided ISBDevice: Arthroscopy-guided SSNBDrug: PlaceboDrug: Ropivacaine

ISB alone

PLACEBO COMPARATOR

During arthroscopic rotator cuff repair, ultrasound-guided ISB was performed preemptively with 7.5 mL ropivacaine immediately after general anesthesia was induced. And at the end of surgery, arthroscopy-guided SSNB was performed with 10 mL normal saline.

Device: Ultrasound-guided ISBDrug: Placebo

Interventions

ISB was performed by one anesthesiologist under ultrasound-guidance. The superior, middle, and inferior trunks of the brachial plexus were identified approximately 2 cm above the clavicle. A 50 mm 22-gauge needle was introduced percutaneously using an out-of-plane technique. The needle was placed beside each trunk in succession, and 2.5 mL ropivacaine was injected into each site. The total volume of ropivacaine used for ISB was 7.5 mL.

ISB aloneISB with SSNB

At the end of the surgery, SSNB was performed under arthroscopic guidance by one shoulder arthroscopist. The suprascapular ligament was found using the lateral portal for visualization. The supraclavicular ligament was visualized at the end of the conoid ligament when the arthroscope was advanced following the coracoclavicular ligament. A 23-gauge spinal needle was introduced in a posteroanterior direction at a 20° angle percutaneously and 7 cm medial to the lateral margin of the acromion. Then, the needle was placed at the upper margin of the suprascapular ligament and advanced slightly under arthroscopy-guidance. After suctioning the saline from the portal, the injection material was administered according to the random assignment.

ISB with SSNB

All the regional blocks in this study were performed using ropivacaine, except for arthroscopy-guided SSNB using placebo (10 mL normal saline)

ISB aloneISB with SSNB

All the regional blocks in this study were performed using 10mL ropivacaine.

ISB with SSNB

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • definite rotator cuff tear on preoperative MRI, which needed repair;
  • acceptance of arthroscopic surgery including rotator cuff repair;
  • \> 20 years old; and
  • acceptance of routine regional blocks and patient-controlled analgesia.

You may not qualify if:

  • did not want arthroscopic rotator cuff repair;
  • stopped PCA before 48 h postoperatively due to side effects;
  • history of shoulder operation or fracture;
  • concomitant neurological disorder around the shoulder;
  • conversion to open surgery from the arthroscopy; and
  • contraindication to the routine regional blocks in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lee JJ, Hwang JT, Kim DY, Lee SS, Hwang SM, Lee NR, Kwak BC. Effects of arthroscopy-guided suprascapular nerve block combined with ultrasound-guided interscalene brachial plexus block for arthroscopic rotator cuff repair: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2017 Jul;25(7):2121-2128. doi: 10.1007/s00167-016-4198-7. Epub 2016 Jun 16.

MeSH Terms

Conditions

Rotator Cuff InjuriesPain, Postoperative

Interventions

Ropivacaine

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon InjuriesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Results Point of Contact

Title
Dr Jung-Taek Hwang
Organization
Chuncheon Sacred Heart Hospital

Study Officials

  • Jung-Taek Hwang, MD, PhD

    Chuncheon Sacred Heart Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 17, 2015

First Posted

April 23, 2015

Study Start

August 1, 2013

Primary Completion

July 1, 2014

Study Completion

December 1, 2014

Last Updated

August 27, 2020

Results First Posted

August 27, 2020

Record last verified: 2020-08